Growth Metrics

Precision Biosciences (DTIL) EPS (Weighted Average and Diluted) (2020 - 2025)

Historic EPS (Weighted Average and Diluted) for Precision Biosciences (DTIL) over the last 6 years, with Q3 2025 value amounting to -$1.84.

  • Precision Biosciences' EPS (Weighted Average and Diluted) rose 1822.22% to -$1.84 in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.92, marking a year-over-year decrease of 1496666.67%. This contributed to the annual value of $1.04 for FY2024, which is 10651.63% up from last year.
  • As of Q3 2025, Precision Biosciences' EPS (Weighted Average and Diluted) stood at -$1.84, which was up 1822.22% from -$2.13 recorded in Q2 2025.
  • Precision Biosciences' EPS (Weighted Average and Diluted)'s 5-year high stood at $4.67 during Q2 2024, with a 5-year trough of -$37.06 in Q4 2022.
  • For the 5-year period, Precision Biosciences' EPS (Weighted Average and Diluted) averaged around -$3.39, with its median value being -$1.98 (2025).
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first plummeted by 965263.16% in 2022, then surged by 24920.13% in 2024.
  • Quarter analysis of 5 years shows Precision Biosciences' EPS (Weighted Average and Diluted) stood at -$0.38 in 2021, then crashed by 9652.63% to -$37.06 in 2022, then surged by 89.04% to -$4.06 in 2023, then rose by 15.04% to -$3.45 in 2024, then skyrocketed by 46.65% to -$1.84 in 2025.
  • Its last three reported values are -$1.84 in Q3 2025, -$2.13 for Q2 2025, and -$2.21 during Q1 2025.